Effects of Raloxifene on Caveolin‐1 mRNA and Protein Expressions in Vascular Smooth Muscle Cells

Caveolin‐1 is regulated by estrogen in vascular smooth muscle cells. Raloxifene, a selective estrogen receptor modulator that possibly has cardioprotective properties without an increased risk of cancer or other side effects of estrogen, may be used in women with risk of coronary artery disease. How...

Full description

Saved in:
Bibliographic Details
Published inActa biochimica et biophysica Sinica Vol. 38; no. 11; pp. 747 - 752
Main Authors YANG, Fa‐Lin, HE, Hong, LIU, Xian‐Xi, TU, Bing, ZENG, Xian‐Wei, SU, Ji‐Xin, WANG, Xin, HU, Qin
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.11.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Caveolin‐1 is regulated by estrogen in vascular smooth muscle cells. Raloxifene, a selective estrogen receptor modulator that possibly has cardioprotective properties without an increased risk of cancer or other side effects of estrogen, may be used in women with risk of coronary artery disease. However, the relationship between raloxifene and caveolin‐1 is still unknown. Therefore, this study was designed to see whether raloxifene regulates caveolin‐1 expression and if so, whether such regulation is mediated by estrogen receptor. Rat aortic smooth muscle cells were cultured in the absence or presence of raloxifene (10−8 to 10−6 M) for 12 or 24 h. Both mRNA and protein levels of caveolin‐1 were increased significantly after 24 h treatment with raloxifene. These increases were inhibited by estrogen receptor antagonist ICI 182780 (10−5 M). Results of this study suggest that raloxifene stimulates caveolin‐1 transcription and translation through estrogen receptor mediated mechanisms. Edited by Autonio CANO
Bibliography:These authors contributed equally to this work
This work was supported by the grants from the Grant‐in‐Aid for Scientific Research of the Ministry of Education, China (No. 2004. 527), the Grant‐in‐Aid for China‐Japan Sasagawa Researchers of the Ministry of Health, China (No. 083), and the Natural Science Foundation of Shandong Province, China (No.Y2005C50)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-9145
1745-7270
DOI:10.1111/j.1745-7270.2006.00222.x